Leukemia Relapse-Associated Mutation of NT5C2 Gene is Rare in de Novo Acute Leukemias and Solid Tumors

Pathol Oncol Res. 2016 Jan;22(1):223-4. doi: 10.1007/s12253-015-9965-0. Epub 2015 Aug 11.

Authors

Hye Rim Oh¹, Youn Jin Choi¹, Nam Jin Yoo¹, Sug Hyung Lee²

Affiliations

¹ Department of Pathology, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Socho-gu, Seoul, 137-701, South Korea.
² Department of Pathology, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Socho-gu, Seoul, 137-701, South Korea. suhulee@catholic.ac.kr.

PMID: 26259531
DOI: 10.1007/s12253-015-9965-0

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

5'-Nucleotidase / genetics*
Biomarkers, Tumor / genetics*
Hematologic Neoplasms / genetics*
Hematologic Neoplasms / pathology
Humans
Mutation / genetics*
Neoplasm Recurrence, Local / genetics*
Neoplasm Recurrence, Local / pathology
Neoplasm Staging
Neoplasms / genetics*
Neoplasms / pathology
Polymerase Chain Reaction
Polymorphism, Single-Stranded Conformational
Prognosis

Substances

Biomarkers, Tumor
5'-Nucleotidase
NT5C2 protein, human